LT - Deriniai, apimantys 6-benzilfenil-2-sieros tetrahidropiran-3,4,5-triolio darinius, kaip natrio-gliukozės bendrų transporterių 1 ir 2 inhibitoriai, skirti naudoti diabetinių pacientų gydymui
EN - COMBINATIONS COMPRISING 6-BENZYLPHENYL-2- SULFURTERAHYDROPYRAN-3,4,5-TRIOL DERIVATIVES AS INHIBITORS OF SODIUM -GLUCOSE COTRANSPORTERS 1 AND 2 FOR USE IN DIABETIC PATIENTS
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 31/351 |
(2006.01) |
|
|
A61P 9/00 |
(2006.01) |
European patent
(11) |
Number of the document |
2542236 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
11707324.7 |
|
Date of filing the European patent application |
2011-03-01 |
(97) |
Date of publication of the European application |
2013-01-09 |
(45) |
Date of publication and mention of the grant of the patent |
2016-10-26
|
(46) |
Date of publication of the claims translation |
2017-03-27
|
PCT application
(86) |
Number |
PCT/US2011/026591 |
|
Date |
2011-03-01 |
PCT application publication
(87) |
Number |
WO 2011/109333 |
|
Date |
2011-09-09 |
Priority applications
(30) |
Number |
Date |
Country code |
|
309592 P |
2010-03-02
|
US |
Inventors
(72) |
BROWN, Philip Manton, US
FREIMAN, Joel Philip, US
POWELL, David Reed, US
|
Grantee
(73) |
Lexicon Pharmaceuticals, Inc.,
8800 Technology Forest Place, The Woodlands, TX 77381,
US
|
Attorney or representative
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
Title
(54) |
Deriniai, apimantys 6-benzilfenil-2-sieros tetrahidropiran-3,4,5-triolio darinius, kaip natrio-gliukozės bendrų transporterių 1 ir 2 inhibitoriai, skirti naudoti diabetinių pacientų gydymui |
|
COMBINATIONS COMPRISING 6-BENZYLPHENYL-2- SULFURTERAHYDROPYRAN-3,4,5-TRIOL DERIVATIVES AS INHIBITORS OF SODIUM -GLUCOSE COTRANSPORTERS 1 AND 2 FOR USE IN DIABETIC PATIENTS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2025-01-21 |
15 |
289.00
EUR
|
Next renewal fee
|
2026-03-01 |